Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME randomized clinical trial (vol 5, pg 164, 2018)
Göster/ Aç
Erişim
info:eu-repo/semantics/openAccessTarih
2019Yazar
Bex, AxelMulders, Peter
Jewett, Michael
Wagstaff, John
Van Thienen, Johannes V.
Blank, Christian U.
Van Velthoven, Roland
Laguna, Maria del Pilar
Wood, Lori
Van Melick, Harm H. E.
Aarts, Maureen J.
Lattouf, Jean-Baptiste
Powles, Thomas
De Jong, Igle Jan
Rottey, Sylvie
Tombal, Bertrand
Marreaud, Sandrine
Collette, Sandra
Collette, Laurence
Haanen, John
Üst veri
Tüm öğe kaydını gösterKünye
Bex, A., Mulders, P., Jewett, M., Wagstaff, J., Van Thienen, J., Blank, C. ... Haanen, J. (2019). Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME randomized clinical trial (vol 5, pg 164, 2018). Journal of Jama Oncology, 5(2), 271-271. https://dx.doi.org/10.1001/jamaoncol.2019.0117Özet
...